Using body-mass index to tell who is overweight or obese is not reliable and can result in misdiagnosis, the Commission on ...

The FDA has designed five different types of labels, each presenting the same information but with different specifications based on the size of the packaging.

Half of the websites (49.4%) failed to mention risks including adverse effects, warnings and precautions, and ...

An international and widely supported group of experts is pushing doctors to avoid the exclusive use of BMI to decide whether ...

BMI has long been falling out of favor. When the American Medical Association urged downgrading BMI in 2023, it blamed its ...

An international group of experts proposes two new categories of disease: preclinical and clinical obesity and the FDA ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Averaging up to 20% of weight loss, adults taking Tirzepatide had at least 25 fewer breathing interruptions each hour as they ...

Donald Trump and his advisers are about to launch a consequential battle against unhealthy food producers and the ...

Treating the growing problem of childhood obesity calls for exploring new approaches and treatments through well-designed ...

CEO Dave Ricks said Monday that the company's weight-loss pill orforglipron could receive FDA approval as soon as early 2026. Read more here.

Sen. Bernie Sanders (I-VT) proposed in February 2024 that the FDA place warning labels about the risk of developing Type 2 diabetes or obesity on foods with high saturated fat, added sugar ...